Park Medi World Limited has informed stock exchanges about a revised timeline for completing its acquisition of SVPD Healthcare Private Limited, extending the deadline to March 31, 2026. The announcement, made through a regulatory filing under SEBI Listing Regulations, provides an update on the company's ongoing acquisition strategy.

Acquisition Background and Progress

The healthcare company initially announced on December 19, 2025, its plan to acquire the 360-bed KP Institute of Medical Sciences in Agra through the acquisition of 100% stakes in two target entities: KPS Wellness Private Limited and SVPD Healthcare Private Limited. The original indicative timeline was set for February 28, 2026.

Park Medi World Limited successfully completed the acquisition of KPS Wellness Private Limited on January 30, 2026, marking the first phase of its expansion strategy.

Timeline Extension Details

The company has now announced that the acquisition of the remaining 100% existing share capital of SVPD Healthcare Private Limited will be completed before March 31, 2026. This revision comes following mutual understanding between SVPD Healthcare Private Limited and Park Medi World Limited.

Regulatory Compliance and Documentation

The disclosure has been made in accordance with Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Park Medi World Limited has confirmed that all other details related to the acquisition remain unchanged from the original announcement.

The company has also indicated that no governmental or regulatory approvals are required for this acquisition. The updated information will be made available on the company's website at www.parkhospital.in as part of its transparency commitments.

Strategic Implications

With the completion of KPS Wellness Private Limited acquisition and the pending acquisition of SVPD Healthcare Private Limited, Park Medi World Limited is positioning itself to operate the 360-bed KP Institute of Medical Sciences facility. The extended timeline provides additional flexibility for completing the transaction while maintaining the strategic objective of expanding the company's healthcare infrastructure capabilities.

Park Medi World Limited announced its revised earnings presentation for Q3 FY26 and nine-month period ended December 31, 2025, showcasing strong operational performance and continued execution of its growth strategy. The company delivered healthy revenue growth supported by stable patient volumes, improved case mix, and gradual ramp-up across newer and acquired hospitals. The company also hosted its maiden earnings call on January 29, 2026, marking the beginning of structured dialogue with the investor community.

Financial Performance Highlights

The company reported impressive financial results across key metrics for both quarterly and nine-month periods:

Revenue from operations reached ₹4,100 mn in Q3 FY26, representing a 17.76% increase from ₹3,481 mn in the corresponding quarter of the previous year. For the nine-month period, revenue grew 17.25% to ₹12,189 mn from ₹10,397 mn in 9M FY25. The company also reported a 24% growth in patient footfall to 6.6 lakh patients in the nine-month period from 5.32 lakh patients in the previous year.

Strategic Acquisitions Drive Expansion

Park Medi World strengthened its platform through two significant strategic acquisitions during the period. The company acquired a 100% stake in KP Institute of Medical Sciences (KPIMS) in an all-cash transaction of ₹245 crore. KPIMS is a 360-bed, NABH-accredited multi super-speciality hospital and among the largest in the Agra region, strengthening Park Group's presence in Uttar Pradesh under its cluster-based expansion strategy.

Additionally, the company acquired Febris Multi-Speciality Hospital in New Delhi through its wholly owned subsidiary Blue Heavens Health Care Pvt. Ltd. under the IBC process. This 200-bed multi-speciality hospital is strategically located in a densely populated catchment with access to Delhi, Haryana, and Western UP.

Operational Excellence and Capacity Expansion

The company demonstrated strong operational metrics with improved capacity utilization:

The company's bed capacity increased to 3,250 beds in 9M FY26 from 3,000 beds in the corresponding previous period. The occupancy ratio improved to 65% in 9M FY26 compared to 62% in 9M FY25, while Average Revenue per Operating Bed (ARPOB) rose to ₹27,406 from ₹25,527.

Aggressive Expansion Plans and Technology Adoption

During the earnings call, management outlined ambitious expansion plans to add 660 beds within FY26 itself. The Agra facility (360 beds) is scheduled to commence operations by February 15, 2026, while the Panchkula Greenfield project (300 beds) will start in the first week of March 2026. By FY28, the company plans to reach approximately 5,260 beds from the current 3,250 beds.

The company has invested heavily in advanced medical technology, including three fifth-generation da Vinci robots for robotic-assisted surgeries. Management reported conducting 25-30 kidney transplants per month and over 300 robotic joint replacements, contributing to improved product mix and higher ARPOB.

Financial Strength and Debt Reduction

Park Medi World significantly strengthened its balance sheet post-IPO. The company reduced its total term debt from ₹425 crore pre-IPO to approximately ₹15 crore as of January 31, 2026, with plans to become completely debt-free by February 2026. This positions the company well for funding its aggressive expansion plans.

Management Outlook and Strategic Focus

According to management commentary during the earnings call, the company remains focused on disciplined capital allocation, balance sheet strength, and measured expansion post-IPO. The company expects to maintain EBITDA margins in the 26%-27% range and PAT margins of 15%-17% over the medium to long term. Management also highlighted the recent CGHS rate hike of 12%-15%, which is expected to benefit the company from FY27, though they are conservatively accounting for a 7.5% impact.

Park Medi World maintains its position as the largest private hospital chain in Haryana with an extensive presence across North India, including Haryana, Delhi, Punjab, and Rajasthan. The company's cluster-based expansion approach enables brand recognition and resource sharing among hospitals located in proximity, supporting operational efficiencies and improved utilization over time.